Braveheart Bio, Inc. ($BRVE)
Filing Information
| Accession Number | 0001470831-26-000804 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
327,777
Total Value
$499,986.00
P&L
+1908.3% (+$9,541,462.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Aug 7, 2026 | Purchase | 27,777 | $18.00 | $499,986.00 | 520,927 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Aug 5, 2026 | Grant/Award | 300,000 | $0.00 | $0.00 | 300,000 | Direct | โ | View Details |